Union for International Cancer Control (UICC)’s Post

How can artificial intelligence be leveraged to improve cancer outcomes while safeguarding patient trust, safety and equity? This morning on the sidelines of #WHA79, UICC and Amgen convened “AI Serving Better Patient Outcomes” to explore how AI can support people-centred cancer care — from earlier and more accurate diagnosis to treatment planning, patient monitoring and supportive care. The discussion highlighted AI’s potential to enhance clinical decision-making, improve efficiency across health systems, and contribute to more personalised care when implemented responsibly and equitably. Thank you to our speakers and to Amgen for partnering with us on this important discussion: 🔸 Thomas Clozel, CEO of Owkin   🔸 Olivier Michielin, Chief of Oncology Department, Geneva University Hospital  🔸 Jenny Ashley, Director of Digital Medicine, Amgen 🔸 Philippe Guinot, Chief Operating Officer, UICC   Moderated by Hannah Vaughan Jones, broadcaster and journalist.